LOINC_NUM
stringlengths 3
8
| COMPONENT
stringlengths 2
246
| PROPERTY
stringlengths 1
29
| TIME_ASPCT
stringlengths 1
15
| SYSTEM
stringlengths 1
106
| SCALE_TYP
stringclasses 10
values | METHOD_TYP
stringlengths 1
57
⌀ | CLASS
stringlengths 2
24
| CLASSTYPE
int64 1
4
| LONG_COMMON_NAME
stringlengths 3
254
| SHORTNAME
stringlengths 2
51
⌀ | EXTERNAL_COPYRIGHT_NOTICE
stringlengths 39
2.6k
⌀ | STATUS
stringclasses 4
values | VersionFirstReleased
stringlengths 1
7
| VersionLastChanged
stringlengths 1
5
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
16164-6 | Parathyrin.intact^2H post XXX challenge | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Parathyrin.intact [Mass/volume] in Serum or Plasma --2 hours post XXX challenge | PTH-Intact 2h p chal SerPl-mCnc | null | ACTIVE | 1.0l | 2.73 |
16165-3 | Glucose^10 AM specimen | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Glucose [Mass/volume] in Serum or Plasma --10 AM specimen | Glucose 10 AM SerPl-mCnc | null | ACTIVE | 1.0l | 2.34 |
16166-1 | Glucose^11 AM specimen | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Glucose [Mass/volume] in Serum or Plasma --11 AM specimen | Glucose 11 AM SerPl-mCnc | null | ACTIVE | 1.0l | 2.34 |
16167-9 | Glucose^2 PM specimen | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Glucose [Mass/volume] in Serum or Plasma --2 PM specimen | Glucose 2 PM SerPl-mCnc | null | ACTIVE | 1.0l | 2.34 |
16168-7 | Glucose^3 PM specimen | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Glucose [Mass/volume] in Serum or Plasma --3 PM specimen | Glucose 3 PM SerPl-mCnc | null | ACTIVE | 1.0l | 2.34 |
16169-5 | Glucose^4 PM specimen | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Glucose [Mass/volume] in Serum or Plasma --4 PM specimen | Glucose 4 PM SerPl-mCnc | null | ACTIVE | 1.0l | 2.73 |
1617-0 | Prolactin^3H post dose L-Dopa PO | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Prolactin [Mass/volume] in Serum or Plasma --3 hours post dose L-dopa PO | Prolactin 3h p L-D PO SerPl-mCnc | null | ACTIVE | 1.0 | 2.40 |
16170-3 | Glucose^5 PM specimen | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Glucose [Mass/volume] in Serum or Plasma --5 PM specimen | Glucose 5 PM SerPl-mCnc | null | ACTIVE | 1.0l | 2.73 |
16171-1 | Cocaethylene | MCnt | Pt | Hair | Qn | null | DRUG/TOX | 1 | Cocaethylene [Mass/mass] in Hair | Cocaethylene Hair-mCnt | null | ACTIVE | 1.0l | 2.73 |
16172-9 | Magnesium | MCnt | Pt | Hair | Qn | null | CHEM | 1 | Magnesium [Mass/mass] in Hair | Magnesium Hair-mCnt | null | ACTIVE | 1.0l | 2.73 |
16173-7 | Amyl ether | MCnc | Pt | Bld | Qn | null | DRUG/TOX | 1 | Amyl ether [Mass/volume] in Blood | Amyl ether Bld-mCnc | null | ACTIVE | 1.0l | 2.34 |
16174-5 | Bartonella henselae Ab.IgG | PrThr | Pt | CSF | Ord | null | MICRO | 1 | Bartonella henselae IgG Ab [Presence] in Cerebral spinal fluid | B henselae IgG CSF Ql | null | ACTIVE | 1.0l | 2.56 |
16175-2 | Bartonella henselae Ab.IgM | PrThr | Pt | CSF | Ord | null | MICRO | 1 | Bartonella henselae IgM Ab [Presence] in Cerebral spinal fluid | B henselae IgM CSF Ql | null | ACTIVE | 1.0l | 2.56 |
16176-0 | Bartonella quintana Ab.IgG | ACnc | Pt | CSF | Qn | null | MICRO | 1 | Bartonella quintana IgG Ab [Units/volume] in Cerebral spinal fluid | B quintana IgG CSF-aCnc | null | ACTIVE | 1.0l | 2.69 |
16177-8 | Bartonella quintana Ab.IgM | ACnc | Pt | CSF | Qn | null | MICRO | 1 | Bartonella quintana IgM Ab [Units/volume] in Cerebral spinal fluid | B quintana IgM CSF-aCnc | null | ACTIVE | 1.0l | 2.69 |
16178-6 | Beryllium | MCnt | Pt | Tiss | Qn | null | DRUG/TOX | 1 | Beryllium [Mass/mass] in Tissue | Beryllium Tiss-mCnt | null | ACTIVE | 1.0l | 2.42 |
16179-4 | Polychlorinated biphenyl | MCnt | Pt | Tiss | Qn | null | DRUG/TOX | 1 | Polychlorinated biphenyl (PCB) [Mass/mass] in Tissue | PCB Tiss-mCnt | null | ACTIVE | 1.0l | 2.46 |
16180-2 | Zinc | MCnt | Pt | Tiss | Qn | null | DRUG/TOX | 1 | Zinc [Mass/mass] in Tissue | Zinc Tiss-mCnt | null | ACTIVE | 1.0l | 2.40 |
16181-0 | Tricyclic antidepressants | MCnc | Pt | Urine | Qn | Confirm | DRUG/TOX | 1 | Tricyclic antidepressants [Mass/volume] in Urine by Confirmatory method | Tricyclics Ur Cfm-mCnc | null | ACTIVE | 1.0l | 2.73 |
16182-8 | Alkaline phosphatase isoenzymes | CCnc | Pt | Ser/Plas | Qn | Heat stability | CHEM | 1 | Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability | ALP Isos SerPl HS-cCnc | null | ACTIVE | 1.0l | 2.73 |
16183-6 | Phenolphthalein | MCnc | Pt | Stool | Qn | null | DRUG/TOX | 1 | Phenolphthalein [Mass/volume] in Stool | Phenolphthalein Stl-mCnc | null | ACTIVE | 1.0l | 2.73 |
16184-4 | Temazepam | MCnc | Pt | Stool | Qn | null | DRUG/TOX | 1 | Temazepam [Mass/volume] in Stool | Temazepam Stl-mCnc | null | ACTIVE | 1.0l | 2.42 |
16185-1 | chlordiazePOXIDE | MCnc | Pt | Stool | Qn | null | DRUG/TOX | 1 | chlordiazePOXIDE [Mass/volume] in Stool | Chlordiazep Stl-mCnc | null | ACTIVE | 1.0l | 2.42 |
16186-9 | Hydroxyalprazolam | MCnc | Pt | Stool | Qn | null | DRUG/TOX | 1 | Hydroxyalprazolam [Mass/volume] in Stool | OH-Alpraz Stl-mCnc | null | ACTIVE | 1.0l | 2.42 |
16187-7 | ALPRAZolam | MCnc | Pt | Stool | Qn | null | DRUG/TOX | 1 | ALPRAZolam [Mass/volume] in Stool | Alpraz Stl-mCnc | null | ACTIVE | 1.0l | 2.42 |
1618-8 | Prolactin^45M post dose insulin IV | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Prolactin [Mass/volume] in Serum or Plasma --45 minutes post dose insulin IV | Prolactin 45M p Ins IV SerPl-mCnc | null | ACTIVE | 1.0 | 2.40 |
16188-5 | Creatinine^2H specimen | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | Creatinine [Mass/volume] in Serum or Plasma --2 hour specimen | Creat 2h spec SerPl-mCnc | null | ACTIVE | 1.0l | 2.73 |
16189-3 | Creatinine^4H specimen | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | Creatinine [Mass/volume] in Serum or Plasma --4 hour specimen | Creat 4h spec SerPl-mCnc | null | ACTIVE | 1.0l | 2.34 |
16190-1 | Amobarbital | PrThr | Pt | Urine | Ord | Confirm | DRUG/TOX | 1 | Amobarbital [Presence] in Urine by Confirmatory method | Amobarbital Ur Ql Cfm | null | ACTIVE | 1.0l | 2.73 |
16191-9 | Butabarbital | PrThr | Pt | Urine | Ord | Confirm | DRUG/TOX | 1 | Butabarbital [Presence] in Urine by Confirmatory method | Butabarbital Ur Ql Cfm | null | ACTIVE | 1.0l | 2.73 |
16192-7 | PHENobarbital | PrThr | Pt | Urine | Ord | Confirm | DRUG/TOX | 1 | PHENobarbital [Presence] in Urine by Confirmatory method | Phenobarb Ur Ql Cfm | null | ACTIVE | 1.0l | 2.73 |
16193-5 | PENTobarbital | PrThr | Pt | Urine | Ord | Confirm | DRUG/TOX | 1 | PENTobarbital [Presence] in Urine by Confirmatory method | Pentobarb Ur Ql Cfm | null | ACTIVE | 1.0l | 2.73 |
16194-3 | Secobarbital | PrThr | Pt | Urine | Ord | Confirm | DRUG/TOX | 1 | Secobarbital [Presence] in Urine by Confirmatory method | Secobarbital Ur Ql Cfm | null | ACTIVE | 1.0l | 2.73 |
16195-0 | Benzodiazepines | PrThr | Pt | Urine | Ord | Confirm | DRUG/TOX | 1 | Benzodiazepines [Presence] in Urine by Confirmatory method | Benzodiaz Ur Ql Cfm | null | ACTIVE | 1.0l | 2.73 |
1619-6 | Prolactin^pre dose L-dopa PO | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Prolactin [Mass/volume] in Serum or Plasma --pre dose L-dopa PO | Prolactin pre L-D PO SerPl-mCnc | null | ACTIVE | 1.0 | 2.40 |
16196-8 | Morphine | PrThr | Pt | Urine | Ord | Confirm | DRUG/TOX | 1 | Morphine [Presence] in Urine by Confirmatory method | Morphine Ur Ql Cfm | null | ACTIVE | 1.0l | 2.73 |
16197-6 | Codeine | PrThr | Pt | Urine | Ord | Confirm | DRUG/TOX | 1 | Codeine [Presence] in Urine by Confirmatory method | Codeine Ur Ql Cfm | null | ACTIVE | 1.0l | 2.73 |
16198-4 | Diamorphine | PrThr | Pt | Urine | Ord | Confirm | DRUG/TOX | 1 | Diamorphine [Presence] in Urine by Confirmatory method | DAM Ur Ql Cfm | null | ACTIVE | 1.0l | 2.56 |
16199-2 | Methadone | PrThr | Pt | Urine | Ord | Confirm | DRUG/TOX | 1 | Methadone [Presence] in Urine by Confirmatory method | Methadone Ur Ql Cfm | null | ACTIVE | 1.0l | 2.73 |
16200-8 | Propoxyphene | PrThr | Pt | Urine | Ord | Confirm | DRUG/TOX | 1 | Propoxyphene [Presence] in Urine by Confirmatory method | Propoxyph Ur Ql Cfm | null | ACTIVE | 1.0l | 2.73 |
16201-6 | Oxazepam | MCnc | Pt | Urine | Qn | Confirm | DRUG/TOX | 1 | Oxazepam [Mass/volume] in Urine by Confirmatory method | Oxazepam Ur Cfm-mCnc | null | ACTIVE | 1.0l | 2.73 |
16202-4 | Nordiazepam | PrThr | Pt | Urine | Ord | Confirm | DRUG/TOX | 1 | Nordiazepam [Presence] in Urine by Confirmatory method | Nordiazepam Ur Ql Cfm | null | ACTIVE | 1.0l | 2.73 |
16203-2 | ALPRAZolam | PrThr | Pt | Urine | Ord | Confirm | DRUG/TOX | 1 | ALPRAZolam [Presence] in Urine by Confirmatory method | Alpraz Ur Ql Cfm | null | ACTIVE | 1.0l | 2.73 |
1620-4 | Prolactin^pre dose TRH IV | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Prolactin [Mass/volume] in Serum or Plasma --pre dose TRH IV | Prolactin pre TRH IV SerPl-mCnc | null | ACTIVE | 1.0 | 2.73 |
16204-0 | clonazePAM | PrThr | Pt | Urine | Ord | Confirm | DRUG/TOX | 1 | clonazePAM [Presence] in Urine by Confirmatory method | clonazePAM Ur Ql Cfm | null | ACTIVE | 1.0l | 2.73 |
16205-7 | LORazepam | PrThr | Pt | Urine | Ord | Confirm | DRUG/TOX | 1 | LORazepam [Presence] in Urine by Confirmatory method | LORazepam Ur Ql Cfm | null | ACTIVE | 1.0l | 2.73 |
16206-5 | Temazepam | PrThr | Pt | Urine | Ord | Confirm | DRUG/TOX | 1 | Temazepam [Presence] in Urine by Confirmatory method | Temazepam Ur Ql Cfm | null | ACTIVE | 1.0l | 2.73 |
16207-3 | Meperidine | PrThr | Pt | Urine | Ord | Confirm | DRUG/TOX | 1 | Meperidine [Presence] in Urine by Confirmatory method | Meperidine Ur Ql Cfm | null | ACTIVE | 1.0l | 2.73 |
16208-1 | Buprenorphine | PrThr | Pt | Urine | Ord | Confirm | DRUG/TOX | 1 | Buprenorphine [Presence] in Urine by Confirmatory method | Buprenorphine Ur Ql Cfm | null | ACTIVE | 1.0l | 2.73 |
16209-9 | Chlorpheniramine | PrThr | Pt | Urine | Ord | Confirm | DRUG/TOX | 1 | Chlorpheniramine [Presence] in Urine by Confirmatory method | Chlorphenir Ur Ql Cfm | null | ACTIVE | 1.0l | 2.73 |
16210-7 | Diethylpropion | PrThr | Pt | Urine | Ord | Confirm | DRUG/TOX | 1 | Diethylpropion [Presence] in Urine by Confirmatory method | Diethylpropion Ur Ql Cfm | null | ACTIVE | 1.0l | 2.73 |
16211-5 | Dihydrocodeine | PrThr | Pt | Urine | Ord | Confirm | DRUG/TOX | 1 | Dihydrocodeine [Presence] in Urine by Confirmatory method | DHC Ur Ql Cfm | null | ACTIVE | 1.0l | 2.73 |
1621-2 | Prolactin^pre dose insulin IV | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Prolactin [Mass/volume] in Serum or Plasma --pre dose insulin IV | Prolactin pre Ins IV SerPl-mCnc | null | ACTIVE | 1.0 | 2.40 |
16212-3 | Ethylamphetamine | PrThr | Pt | Urine | Ord | Confirm | DRUG/TOX | 1 | Ethylamphetamine [Presence] in Urine by Confirmatory method | Ethylamphet Ur Ql Cfm | null | ACTIVE | 1.0l | 2.73 |
16213-1 | Levorphanol | PrThr | Pt | Urine | Ord | Confirm | DRUG/TOX | 1 | Levorphanol [Presence] in Urine by Confirmatory method | Levorphanol Ur Ql Cfm | null | ACTIVE | 1.0l | 2.56 |
16214-9 | Lysergate diethylamide | PrThr | Pt | Urine | Ord | Confirm | DRUG/TOX | 1 | Lysergate diethylamide [Presence] in Urine by Confirmatory method | LSD Ur Ql Cfm | null | ACTIVE | 1.0l | 2.56 |
16215-6 | Mephobarbital | MCnc | Pt | Ser/Plas | Qn | Confirm | DRUG/TOX | 1 | Mephobarbital [Mass/volume] in Serum or Plasma by Confirmatory method | Mephobarbital SerPl Cfm-mCnc | null | ACTIVE | 1.0l | 2.40 |
16216-4 | MethylePHEDrine | PrThr | Pt | Urine | Ord | Confirm | DRUG/TOX | 1 | MethylePHEDrine [Presence] in Urine by Confirmatory method | Me-ePHEDrine Ur Ql Cfm | null | ACTIVE | 1.0l | 2.56 |
16217-2 | Methyprylon | PrThr | Pt | Urine | Ord | Confirm | DRUG/TOX | 1 | Methyprylon [Presence] in Urine by Confirmatory method | Methyprylon Ur Ql Cfm | null | ACTIVE | 1.0l | 2.56 |
16218-0 | Nalbuphine | PrThr | Pt | Urine | Ord | Confirm | DRUG/TOX | 1 | Nalbuphine [Presence] in Urine by Confirmatory method | Nalbuphine Ur Ql Cfm | null | ACTIVE | 1.0l | 2.73 |
16219-8 | Pentazocine | PrThr | Pt | Urine | Ord | Confirm | DRUG/TOX | 1 | Pentazocine [Presence] in Urine by Confirmatory method | Pentazocine Ur Ql Cfm | null | ACTIVE | 1.0l | 2.73 |
1622-0 | Renin^5H post 600 ug furosemide PO | CCnc | Pt | Plas | Qn | null | CHAL | 1 | Renin [Enzymatic activity/volume] in Plasma --5 hours post 600 ug furosemide PO | Renin 5h p 600 ug Fur PO Plas-cCnc | null | ACTIVE | 1.0 | 2.42 |
16220-6 | Phenmetrazine | PrThr | Pt | Urine | Ord | Confirm | DRUG/TOX | 1 | Phenmetrazine [Presence] in Urine by Confirmatory method | Phenmetrazine Ur Ql Cfm | null | ACTIVE | 1.0l | 2.73 |
16221-4 | Phenothiazines | PrThr | Pt | Urine | Ord | Confirm | DRUG/TOX | 1 | Phenothiazines [Presence] in Urine by Confirmatory method | Phenothiaz Ur Ql Cfm | null | ACTIVE | 1.0l | 2.70 |
16222-2 | Phentermine | PrThr | Pt | Urine | Ord | Confirm | DRUG/TOX | 1 | Phentermine [Presence] in Urine by Confirmatory method | Phentermine Ur Ql Cfm | null | ACTIVE | 1.0l | 2.73 |
16223-0 | Thiopental | PrThr | Pt | Urine | Ord | Confirm | DRUG/TOX | 1 | Thiopental [Presence] in Urine by Confirmatory method | Thiopental Ur Ql Cfm | null | ACTIVE | 1.0l | 2.73 |
16224-8 | Triazolam | PrThr | Pt | Urine | Ord | Confirm | DRUG/TOX | 1 | Triazolam [Presence] in Urine by Confirmatory method | Triazolam Ur Ql Cfm | null | ACTIVE | 1.0l | 2.56 |
16225-5 | Amitriptyline | PrThr | Pt | Urine | Ord | Confirm | DRUG/TOX | 1 | Amitriptyline [Presence] in Urine by Confirmatory method | Amitrip Ur Ql Cfm | null | ACTIVE | 1.0l | 2.73 |
16226-3 | Benzoylecgonine | MCnc | Pt | Urine | Qn | Confirm | DRUG/TOX | 1 | Benzoylecgonine [Mass/volume] in Urine by Confirmatory method | BZE Ur Cfm-mCnc | null | ACTIVE | 1.0l | 2.73 |
16227-1 | diazePAM | MCnc | Pt | Urine | Qn | Confirm | DRUG/TOX | 1 | diazePAM [Mass/volume] in Urine by Confirmatory method | diazePAM Ur Cfm-mCnc | null | ACTIVE | 1.0l | 2.73 |
16228-9 | Nordiazepam | MCnc | Pt | Urine | Qn | Confirm | DRUG/TOX | 1 | Nordiazepam [Mass/volume] in Urine by Confirmatory method | Nordiazepam Ur Cfm-mCnc | null | ACTIVE | 1.0l | 2.73 |
16229-7 | clonazePAM | MCnc | Pt | Urine | Qn | Confirm | DRUG/TOX | 1 | clonazePAM [Mass/volume] in Urine by Confirmatory method | clonazePAM Ur Cfm-mCnc | null | ACTIVE | 1.0l | 2.73 |
16230-5 | N-desalkylflurazepam | MCnc | Pt | Urine | Qn | Confirm | DRUG/TOX | 1 | N-desalkylflurazepam [Mass/volume] in Urine by Confirmatory method | Desalkylfluraz Ur Cfm-mCnc | null | ACTIVE | 1.0l | 2.73 |
16231-3 | Flurazepam | MCnc | Pt | Urine | Qn | Confirm | DRUG/TOX | 1 | Flurazepam [Mass/volume] in Urine by Confirmatory method | Flurazepam Ur Cfm-mCnc | null | ACTIVE | 1.0l | 2.73 |
16232-1 | Triazolam | MCnc | Pt | Urine | Qn | Confirm | DRUG/TOX | 1 | Triazolam [Mass/volume] in Urine by Confirmatory method | Triazolam Ur Cfm-mCnc | null | ACTIVE | 1.0l | 2.73 |
16233-9 | Midazolam | MCnc | Pt | Urine | Qn | Confirm | DRUG/TOX | 1 | Midazolam [Mass/volume] in Urine by Confirmatory method | Midazolam Ur Cfm-mCnc | null | ACTIVE | 1.0l | 2.73 |
16234-7 | Amphetamine | MCnc | Pt | Urine | Qn | Confirm | DRUG/TOX | 1 | Amphetamine [Mass/volume] in Urine by Confirmatory method | Amphet Ur Cfm-mCnc | null | ACTIVE | 1.0l | 2.73 |
16235-4 | Methamphetamine | MCnc | Pt | Urine | Qn | Confirm | DRUG/TOX | 1 | Methamphetamine [Mass/volume] in Urine by Confirmatory method | Methamphet Ur Cfm-mCnc | null | ACTIVE | 1.0l | 2.73 |
16236-2 | Butabarbital | MCnc | Pt | Urine | Qn | Confirm | DRUG/TOX | 1 | Butabarbital [Mass/volume] in Urine by Confirmatory method | Butabarbital Ur Cfm-mCnc | null | ACTIVE | 1.0l | 2.73 |
16237-0 | Butalbital | MCnc | Pt | Urine | Qn | Confirm | DRUG/TOX | 1 | Butalbital [Mass/volume] in Urine by Confirmatory method | Butalbital Ur Cfm-mCnc | null | ACTIVE | 1.0l | 2.73 |
1623-8 | Renin^pre 600 ug furosemide PO | CCnc | Pt | Plas | Qn | null | CHAL | 1 | Renin [Enzymatic activity/volume] in Plasma --pre 600 ug furosemide PO | Renin pre 600 ug Fur PO Plas-cCnc | null | ACTIVE | 1.0 | 2.42 |
16238-8 | Secobarbital | MCnc | Pt | Urine | Qn | Confirm | DRUG/TOX | 1 | Secobarbital [Mass/volume] in Urine by Confirmatory method | Secobarbital Ur Cfm-mCnc | null | ACTIVE | 1.0l | 2.73 |
16239-6 | Amobarbital | MCnc | Pt | Urine | Qn | Confirm | DRUG/TOX | 1 | Amobarbital [Mass/volume] in Urine by Confirmatory method | Amobarbital Ur Cfm-mCnc | null | ACTIVE | 1.0l | 2.73 |
16240-4 | PENTobarbital | MCnc | Pt | Urine | Qn | Confirm | DRUG/TOX | 1 | PENTobarbital [Mass/volume] in Urine by Confirmatory method | Pentobarb Ur Cfm-mCnc | null | ACTIVE | 1.0l | 2.73 |
16241-2 | PHENobarbital | MCnc | Pt | Urine | Qn | Confirm | DRUG/TOX | 1 | PHENobarbital [Mass/volume] in Urine by Confirmatory method | Phenobarb Ur Cfm-mCnc | null | ACTIVE | 1.0l | 2.73 |
16242-0 | Propoxyphene | MCnc | Pt | Urine | Qn | Confirm | DRUG/TOX | 1 | Propoxyphene [Mass/volume] in Urine by Confirmatory method | Propoxyph Ur Cfm-mCnc | null | ACTIVE | 1.0l | 2.73 |
16243-8 | Cannabinoids | MCnc | Pt | Bld | Qn | Confirm | DRUG/TOX | 1 | Cannabinoids [Mass/volume] in Blood by Confirmatory method | Cannabinoids Bld Cfm-mCnc | null | ACTIVE | 1.0l | 2.73 |
16244-6 | Methaqualone | MCnc | Pt | Urine | Qn | Confirm | DRUG/TOX | 1 | Methaqualone [Mass/volume] in Urine by Confirmatory method | Methaqualone Ur Cfm-mCnc | null | ACTIVE | 1.0l | 2.73 |
16245-3 | Hydroxyethylflurazepam | MCnc | Pt | Ser/Plas | Qn | Confirm | DRUG/TOX | 1 | Hydroxyethylflurazepam [Mass/volume] in Serum or Plasma by Confirmatory method | OH-Ethylfluraz SerPl Cfm-mCnc | null | ACTIVE | 1.0l | 2.73 |
1624-6 | Retinol^3H post 5000 units | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Retinol [Mass/volume] in Serum or Plasma --3 hours post 5000 units | Vit A 3h p 5000 U SerPl-mCnc | null | ACTIVE | 1.0 | 2.40 |
16246-1 | Methadone | MCnc | Pt | Urine | Qn | Confirm | DRUG/TOX | 1 | Methadone [Mass/volume] in Urine by Confirmatory method | Methadone Ur Cfm-mCnc | null | ACTIVE | 1.0l | 2.73 |
16247-9 | Dextromethorphan | MCnc | Pt | Ser/Plas | Qn | Confirm | DRUG/TOX | 1 | Dextromethorphan [Mass/volume] in Serum or Plasma by Confirmatory method | D-methorphan SerPl Cfm-mCnc | null | ACTIVE | 1.0l | 2.40 |
16248-7 | 6-Monoacetylmorphine.free | MCnc | Pt | Ser/Plas | Qn | Confirm | DRUG/TOX | 1 | 6-monoacetylmorphine free [Mass/volume] in Serum or Plasma by Confirmatory method | 6MAM Free SerPl Cfm-mCnc | null | ACTIVE | 1.0l | 2.73 |
16249-5 | oxyCODONE | MCnc | Pt | Urine | Qn | Confirm | DRUG/TOX | 1 | oxyCODONE [Mass/volume] in Urine by Confirmatory method | oxyCODONE Ur Cfm-mCnc | null | ACTIVE | 1.0l | 2.73 |
16250-3 | Codeine | MCnc | Pt | Urine | Qn | Confirm | DRUG/TOX | 1 | Codeine [Mass/volume] in Urine by Confirmatory method | Codeine Ur Cfm-mCnc | null | ACTIVE | 1.0l | 2.73 |
16251-1 | Morphine | MCnc | Pt | Urine | Qn | Confirm | DRUG/TOX | 1 | Morphine [Mass/volume] in Urine by Confirmatory method | Morphine Ur Cfm-mCnc | null | ACTIVE | 1.0l | 2.73 |
16252-9 | HYDROcodone | MCnc | Pt | Urine | Qn | Confirm | DRUG/TOX | 1 | HYDROcodone [Mass/volume] in Urine by Confirmatory method | HYDROcodone Ur Cfm-mCnc | null | ACTIVE | 1.0l | 2.73 |
1625-3 | Retinol^6H post 5000 units | MCnc | Pt | Ser/Plas | Qn | null | CHAL | 1 | Retinol [Mass/volume] in Serum or Plasma --6 hours post 5000 units | Vit A 6h p 5000 U SerPl-mCnc | null | ACTIVE | 1.0 | 2.40 |
16253-7 | Meperidine | MCnc | Pt | Urine | Qn | Confirm | DRUG/TOX | 1 | Meperidine [Mass/volume] in Urine by Confirmatory method | Meperidine Ur Cfm-mCnc | null | ACTIVE | 1.0l | 2.73 |
16254-5 | Phencyclidine | MCnc | Pt | Urine | Qn | Confirm | DRUG/TOX | 1 | Phencyclidine [Mass/volume] in Urine by Confirmatory method | PCP Ur Cfm-mCnc | null | ACTIVE | 1.0l | 2.73 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.